CopayAGSubachBRGlassmanSDPollyDWSchulerTC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 2007;7(5):541-546.
2.
KunzeKNBartJAAhmadMNhoSJChahlaJ. Large heterogeneity among minimal clinically important differences for hip arthroscopy outcomes: a systematic review of reporting trends and quantification methods. Arthroscopy. 2021;37(3):1028-1037.e6.
3.
NormanGRSloanJAWyrwichKW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582-592.
4.
SchistermanEFFaraggiDReiserBHuJ. Youden index and the optimal threshold for markers with mass at zero. Stat Med. 2008;27(2):297-315.
5.
TerlePMPeeblesLAVermaAKraeutlerMJ. Minimal clinically important difference, substantial clinical benefit, and Patient Acceptable Symptom State values after hip arthroscopy for femoroacetabular impingement are highly dependent on their study population and calculation methods: a systematic review. Arthroscopy. 2025;41(6):2105-2113.
6.
WalshEGWallaceIAQuesada-JimenezRKahana-RojkindAHDombBG. Clinically relevant thresholds for hip arthroscopy vary: a systematic review. Arthroscopy. 2025;41(8):3115-3137.
7.
WattJAVeronikiAATriccoACStrausSE. Using a distribution-based approach and systematic review methods to derive minimum clinically important differences. BMC Med Res Methodol. 2021;21(1):41.
